No evidence for association of the polymorphisms in NLRP1 gene with type 1 diabetes in Poland

Diabetes Research and Clinical Practice

Volumn 92, Issue 3, 2011, Pages

  Zurawek, Magdalena ^a   Fichna, Marta ^b   Fichna, Piotr ^b   Januszkiewicz, Danuta ^b   Nowak, Jerzy ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; NLRP1 GENE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLAND; POLYMORPHISM, GENETIC;

EID: 79958000168     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.02.004     Document Type: Letter

References (10)

1. Cucca F., Lampis R., Congia M., Angius E., Nutland S., Bain S.C., et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 2001, 10:2025-2037.
2. Bell G.I., Horita S., Karam J.H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984, 33:176-183.
3. Barratt B.J., Payne F., Lowe C.E., Hermann R., Healy B.C., Harold D., et al. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 2004, 53:1884-1889.
4. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
5. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337-338.
6. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356:1216-1225.
7. Tschopp J., Martinon F., Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003, 4:95-104.
8. Magitta N.F., Bøe Wolff A.S., Johansson S., Skinningsrud B., Lie B.A., Myhr K.M., et al. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun 2009, 10:120-124.
9. Zurawek M., Fichna M., Januszkiewicz-Lewandowska D., Gryczyńska M., Fichna P., Nowak J. A coding variant in NLRP1 is associated with autoimmune Addison's disease. Hum Immunol 2010, 71:530-534.
10. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447:661-78.